Terumo Corporation (TRUMF)
- Business Wire
MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth
ALISO VIEJO, Calif., September 12, 2024--MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.
- Zacks
What Makes Terumo (TRUMY) a New Buy Stock
Terumo (TRUMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- PR Newswire
Terumo Establishes Corporate Venture Capital "Terumo Ventures"
Terumo Corporation (TSE: 4543) today announced that it has established "Terumo Ventures," a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, as a department within Terumo Americas Holding, Inc.
